PubMed:26684240 / 286-560
Annnotations
LitCoin-entities
{"project":"LitCoin-entities","denotations":[{"id":"10976","span":{"begin":48,"end":56},"obj":"DiseaseOrPhenotypicFeature"},{"id":"10977","span":{"begin":62,"end":70},"obj":"OrganismTaxon"},{"id":"10978","span":{"begin":147,"end":156},"obj":"ChemicalEntity"},{"id":"10979","span":{"begin":250,"end":264},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A6","pred":"db_id","subj":"10976","obj":"MESH:C535650"},{"id":"A7","pred":"db_id","subj":"10977","obj":"NCBITaxon:9606"},{"id":"A8","pred":"db_id","subj":"10978","obj":"MESH:C516667"},{"id":"A9","pred":"db_id","subj":"10979","obj":"MESH:D007414"}],"namespaces":[{"prefix":"_base","uri":"https://w3id.org/biolink/vocab/"},{"prefix":"MESH","uri":"http://id.nlm.nih.gov/mesh/"},{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id="},{"prefix":"NCBIGene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"OMIM","uri":"https://www.omim.org/entry/"},{"prefix":"DBSNP","uri":"https://www.ncbi.nlm.nih.gov/snp/"}],"text":"Here, we performed whole exome sequencing of 12 GEP-NETs from patients enrolled in a nonrandomized, open-labeled, single-center phase II study for pazopanib, and integrated our results with previously published results on pancreas (n = 12) and small intestine NETs (n = 50)."}
LitCoin-sentences
{"project":"LitCoin-sentences","denotations":[{"id":"T3","span":{"begin":0,"end":274},"obj":"Sentence"}],"text":"Here, we performed whole exome sequencing of 12 GEP-NETs from patients enrolled in a nonrandomized, open-labeled, single-center phase II study for pazopanib, and integrated our results with previously published results on pancreas (n = 12) and small intestine NETs (n = 50)."}
LitCoin-GeneOrGeneProduct-v2
{"project":"LitCoin-GeneOrGeneProduct-v2","denotations":[{"id":"T2","span":{"begin":244,"end":249},"obj":"GeneOrGeneProduct"}],"text":"Here, we performed whole exome sequencing of 12 GEP-NETs from patients enrolled in a nonrandomized, open-labeled, single-center phase II study for pazopanib, and integrated our results with previously published results on pancreas (n = 12) and small intestine NETs (n = 50)."}
LitCoin-GeneOrGeneProduct-v0
{"project":"LitCoin-GeneOrGeneProduct-v0","denotations":[{"id":"T6","span":{"begin":25,"end":30},"obj":"GeneOrGeneProduct"},{"id":"T7","span":{"begin":52,"end":56},"obj":"GeneOrGeneProduct"},{"id":"T8","span":{"begin":80,"end":84},"obj":"GeneOrGeneProduct"},{"id":"T9","span":{"begin":100,"end":104},"obj":"GeneOrGeneProduct"},{"id":"T10","span":{"begin":134,"end":136},"obj":"GeneOrGeneProduct"},{"id":"T11","span":{"begin":232,"end":238},"obj":"GeneOrGeneProduct"},{"id":"T12","span":{"begin":244,"end":249},"obj":"GeneOrGeneProduct"},{"id":"T13","span":{"begin":250,"end":259},"obj":"GeneOrGeneProduct"},{"id":"T14","span":{"begin":260,"end":264},"obj":"GeneOrGeneProduct"},{"id":"T15","span":{"begin":266,"end":272},"obj":"GeneOrGeneProduct"}],"text":"Here, we performed whole exome sequencing of 12 GEP-NETs from patients enrolled in a nonrandomized, open-labeled, single-center phase II study for pazopanib, and integrated our results with previously published results on pancreas (n = 12) and small intestine NETs (n = 50)."}
LitCoin_Mondo_095
{"project":"LitCoin_Mondo_095","denotations":[{"id":"T3","span":{"begin":222,"end":230},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T4","span":{"begin":244,"end":264},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A3","pred":"mondo_id","subj":"T3","obj":"0021040"},{"id":"A4","pred":"mondo_id","subj":"T4","obj":"0018510"}],"text":"Here, we performed whole exome sequencing of 12 GEP-NETs from patients enrolled in a nonrandomized, open-labeled, single-center phase II study for pazopanib, and integrated our results with previously published results on pancreas (n = 12) and small intestine NETs (n = 50)."}
LitCoin-MeSH-Disease-2
{"project":"LitCoin-MeSH-Disease-2","denotations":[{"id":"T4","span":{"begin":48,"end":56},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T5","span":{"begin":250,"end":264},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A4","pred":"ID:","subj":"T4","obj":"DISEASE"},{"id":"A5","pred":"ID:","subj":"T5","obj":"DISEASE"}],"text":"Here, we performed whole exome sequencing of 12 GEP-NETs from patients enrolled in a nonrandomized, open-labeled, single-center phase II study for pazopanib, and integrated our results with previously published results on pancreas (n = 12) and small intestine NETs (n = 50)."}
LitCoin-MONDO_bioort2019
{"project":"LitCoin-MONDO_bioort2019","denotations":[{"id":"T4","span":{"begin":48,"end":56},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T5","span":{"begin":250,"end":264},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A4","pred":"#label","subj":"T4","obj":"DISEASE"},{"id":"A5","pred":"#label","subj":"T5","obj":"DISEASE"}],"text":"Here, we performed whole exome sequencing of 12 GEP-NETs from patients enrolled in a nonrandomized, open-labeled, single-center phase II study for pazopanib, and integrated our results with previously published results on pancreas (n = 12) and small intestine NETs (n = 50)."}
LitCoin-Chemical-MeSH-CHEBI
{"project":"LitCoin-Chemical-MeSH-CHEBI","denotations":[{"id":"T1","span":{"begin":147,"end":156},"obj":"ChemicalEntity"}],"attributes":[{"id":"A1","pred":"ID:","subj":"T1","obj":"C516667"},{"id":"A2","pred":"ID:","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_71219"}],"text":"Here, we performed whole exome sequencing of 12 GEP-NETs from patients enrolled in a nonrandomized, open-labeled, single-center phase II study for pazopanib, and integrated our results with previously published results on pancreas (n = 12) and small intestine NETs (n = 50)."}
LitCoin-NCBITaxon-2
{"project":"LitCoin-NCBITaxon-2","denotations":[{"id":"T1","span":{"begin":62,"end":70},"obj":"OrganismTaxon"}],"text":"Here, we performed whole exome sequencing of 12 GEP-NETs from patients enrolled in a nonrandomized, open-labeled, single-center phase II study for pazopanib, and integrated our results with previously published results on pancreas (n = 12) and small intestine NETs (n = 50)."}
LitCoin-training-merged
{"project":"LitCoin-training-merged","denotations":[{"id":"T1","span":{"begin":147,"end":156},"obj":"ChemicalEntity"},{"id":"T20728","span":{"begin":250,"end":264},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T93864","span":{"begin":48,"end":56},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T66225","span":{"begin":62,"end":70},"obj":"OrganismTaxon"}],"attributes":[{"id":"A2","pred":"ID:","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_71219"},{"id":"A1","pred":"ID:","subj":"T1","obj":"C516667"},{"id":"A26303","pred":"#label","subj":"T20728","obj":"DISEASE"},{"id":"A66920","pred":"#label","subj":"T93864","obj":"DISEASE"}],"text":"Here, we performed whole exome sequencing of 12 GEP-NETs from patients enrolled in a nonrandomized, open-labeled, single-center phase II study for pazopanib, and integrated our results with previously published results on pancreas (n = 12) and small intestine NETs (n = 50)."}